GT200600183A - Sistema terapeuticio transdermico solidio con absorbedor uv. - Google Patents
Sistema terapeuticio transdermico solidio con absorbedor uv.Info
- Publication number
- GT200600183A GT200600183A GT200600183A GT200600183A GT200600183A GT 200600183 A GT200600183 A GT 200600183A GT 200600183 A GT200600183 A GT 200600183A GT 200600183 A GT200600183 A GT 200600183A GT 200600183 A GT200600183 A GT 200600183A
- Authority
- GT
- Guatemala
- Prior art keywords
- active substance
- matrix containing
- base layer
- containing active
- stt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCIÓN SE REFIERE A UN NUEVO SISTEMA TERAÉUTICO TRANSDERMICO SÓLIDO CON ABSORBEDPR UV DISEÑADO ESPECIALMENTE PARA SUSTANCIAS ACTIVAS FARMACÉUTICAS SENSIBLE A LA LUZ. EL SISTEMA TERAPÉUTICO TRANSDÉRMICO (STT) ESTABLE A LOS RAYOS UV COMPRENDE UNA CAPA DE BASE 1, AL MENOS UNA MATRIZ QUE CONTIENE SUSTANCIA ACTIVA 2 Y UNA PELÍCULA PROTECTORA DESPRENDIBLE 3, DONDE OPCIONALMENTE SE PUEDE INTERCALAR UNA CAPA ADHESIVA 4 Y UNA CAPA SEPARADORA 5 ENTRE LA CAPA DE BASE 2 Y LA MATRIZ QUE CONTIENE SUSTANCIA ACTIVA 2. EN LA CAPA DE BASE 1 O EN LA MATRIZ QUE CONTIENE SUSTNACIA ACTIVA 2 O EN LA CAPA ADHESIVA 4 SE PUEDEN INCLUIR ABSORBEDORES UV DEL GRUPO DE LAS HIDROXI-FENILTRIAZINAS. EL STT DE LA INVENCIÓN PRESENTA UNA ELEVADA ESTABILIDAD CON BAJA CONCENTRACIÓN DE ABSORBEDORES UV. CON ELLO SE PUEDE EVITAR O REDUCIR ESPECIALMENTE EL RIESGO DE UNA POSIBLE IRRITACIÓN CUTÁNEA. T2006
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05009579A EP1719504A1 (de) | 2005-05-02 | 2005-05-02 | Festes transdermales therapeutisches System mit UV-Absorber |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200600183A true GT200600183A (es) | 2007-01-03 |
Family
ID=34981458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200600183A GT200600183A (es) | 2005-05-02 | 2006-04-28 | Sistema terapeuticio transdermico solidio con absorbedor uv. |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP1719504A1 (es) |
| JP (2) | JP5360877B2 (es) |
| KR (2) | KR101351161B1 (es) |
| CN (2) | CN101171001A (es) |
| AR (1) | AR055927A1 (es) |
| AU (1) | AU2006243442A1 (es) |
| BR (1) | BRPI0611087A2 (es) |
| CA (1) | CA2605112C (es) |
| CR (1) | CR9483A (es) |
| CY (1) | CY1115757T1 (es) |
| DK (1) | DK1879560T3 (es) |
| DO (1) | DOP2006000100A (es) |
| EA (1) | EA200702344A1 (es) |
| ES (1) | ES2523663T3 (es) |
| GT (1) | GT200600183A (es) |
| IL (1) | IL186945A0 (es) |
| MX (1) | MX2007013779A (es) |
| NO (1) | NO20076187L (es) |
| PE (1) | PE20061414A1 (es) |
| PL (1) | PL1879560T3 (es) |
| PT (1) | PT1879560E (es) |
| SI (1) | SI1879560T1 (es) |
| TW (1) | TW200719902A (es) |
| UY (1) | UY29511A1 (es) |
| WO (1) | WO2006117139A2 (es) |
| ZA (1) | ZA200710418B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1594483B1 (de) | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
| US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| EP2613772B1 (en) * | 2010-09-06 | 2016-12-14 | Bayer Intellectual Property GmbH | Low-dose transdermal patches with high drug release |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023084A (en) * | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
| DE59107052D1 (de) * | 1990-03-30 | 1996-01-25 | Ciba Geigy Ag | Lackzusammensetzungen |
| US8173592B1 (en) * | 1999-03-31 | 2012-05-08 | Zentaris Ivf Gmbh | Method for a programmed controlled ovarian stimulation protocol |
| US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
| BRPI0109198B8 (pt) | 2000-03-17 | 2021-05-25 | Hisamitsu Pharmaceutical Co | emplastro tendo um apoio |
| EP1594483B1 (de) * | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
| EP1452173A1 (de) * | 2003-02-25 | 2004-09-01 | Schering AG | UV-stabiles transdermales Pflaster |
| DE602004019230D1 (de) * | 2003-09-11 | 2009-03-12 | Ciba Holding Inc | Auf wasser basierende konzentrierte produktformen von lichtschutzmitteln, hergestellt nach einer heterophasen-polymerisationstechnik |
-
2005
- 2005-05-02 EP EP05009579A patent/EP1719504A1/de not_active Withdrawn
-
2006
- 2006-04-28 WO PCT/EP2006/003959 patent/WO2006117139A2/de active Application Filing
- 2006-04-28 GT GT200600183A patent/GT200600183A/es unknown
- 2006-04-28 PT PT67534412T patent/PT1879560E/pt unknown
- 2006-04-28 CN CNA2006800151185A patent/CN101171001A/zh active Pending
- 2006-04-28 JP JP2008509340A patent/JP5360877B2/ja not_active Expired - Fee Related
- 2006-04-28 DK DK06753441.2T patent/DK1879560T3/en active
- 2006-04-28 DO DO2006000100A patent/DOP2006000100A/es unknown
- 2006-04-28 PE PE2006000451A patent/PE20061414A1/es not_active Application Discontinuation
- 2006-04-28 ES ES06753441.2T patent/ES2523663T3/es active Active
- 2006-04-28 EA EA200702344A patent/EA200702344A1/ru unknown
- 2006-04-28 KR KR1020077025388A patent/KR101351161B1/ko active IP Right Grant
- 2006-04-28 MX MX2007013779A patent/MX2007013779A/es not_active Application Discontinuation
- 2006-04-28 CN CN201810889234.4A patent/CN108969507A/zh not_active Withdrawn
- 2006-04-28 PL PL06753441T patent/PL1879560T3/pl unknown
- 2006-04-28 EP EP06753441.2A patent/EP1879560B1/de active Active
- 2006-04-28 AU AU2006243442A patent/AU2006243442A1/en not_active Abandoned
- 2006-04-28 BR BRPI0611087-8A patent/BRPI0611087A2/pt not_active Application Discontinuation
- 2006-04-28 UY UY29511A patent/UY29511A1/es not_active Application Discontinuation
- 2006-04-28 SI SI200631854T patent/SI1879560T1/sl unknown
- 2006-04-28 KR KR1020137019206A patent/KR101426218B1/ko active IP Right Grant
- 2006-04-28 AR ARP060101711A patent/AR055927A1/es not_active Application Discontinuation
- 2006-04-28 CA CA2605112A patent/CA2605112C/en not_active Expired - Fee Related
- 2006-05-02 TW TW095115581A patent/TW200719902A/zh unknown
-
2007
- 2007-10-25 IL IL186945A patent/IL186945A0/en unknown
- 2007-10-30 CR CR9483A patent/CR9483A/es not_active Application Discontinuation
- 2007-11-30 ZA ZA200710418A patent/ZA200710418B/xx unknown
- 2007-11-30 NO NO20076187A patent/NO20076187L/no not_active Application Discontinuation
-
2013
- 2013-06-12 JP JP2013123885A patent/JP2013177451A/ja not_active Withdrawn
-
2014
- 2014-11-13 CY CY20141100949T patent/CY1115757T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28189A1 (es) | Sistema terapéutico transdérmico estable a los rayos uv. | |
| ES2581574T3 (es) | Sistema terapéutico transdérmico para la administración del principio activo buprenorfina | |
| ES2581985T3 (es) | Sistema terapéutico transdérmico que contiene norelgestromina para la contracepción y el reemplazo hormonal | |
| AR097045A2 (es) | Sistema terapéutico transdérmico | |
| ES2185817T3 (es) | Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato. | |
| ES2114423B1 (es) | Nuevas composiciones farmaceuticas de liberacion de farmaco controlada por difusion-osmosis y procesos para preparar las mismas. | |
| GT200600183A (es) | Sistema terapeuticio transdermico solidio con absorbedor uv. | |
| CY1108250T1 (el) | Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη του | |
| PE20070312A1 (es) | Estuche para alojar un envase con medicamento | |
| BR0313091A (pt) | Sistema de liberação transdérmica aperfeiçoado para a administração de rotigotina | |
| PE20070432A1 (es) | Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) o sus sales | |
| PA8594801A1 (es) | Formulaciones farmaceuticas liquidas de palanosetron | |
| AR070031A1 (es) | Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas | |
| AR033748A1 (es) | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo | |
| AR054012A1 (es) | Sistema terapeutico transdermico para la adminstracion de analgesicos | |
| BR0313092A (pt) | Sistema de liberação transdérmica aperfeiçoado | |
| AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
| AR026038A1 (es) | Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion | |
| CR8461A (es) | Forma de administracion transdermica, liquida o semisolida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas | |
| ATE471715T1 (de) | Arzneimittelpräparat für perkutane absorption | |
| BRPI0011135B8 (pt) | sistema de ministração terapêutica transdérmica contendo agente neuroléptico | |
| CU23518A3 (es) | Sistema terapéutico transdérmico estable a los rayos ultravioletas | |
| CO5640059A2 (es) | Uso de clorofila para el control de malos olores en articulos absorbentes desechables | |
| CU20060115A7 (es) | Forma de administración transdérmica, líquida o semisólida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas | |
| AR082906A1 (es) | Parches transdermicos de dosis baja con nivel elevado de liberacion de droga |